Menu
GeneBe

rs150914617

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000162.5(GCK):c.1019+18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00402 in 1,600,426 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0041 ( 19 hom. )

Consequence

GCK
NM_000162.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.922
Variant links:
Genes affected
GCK (HGNC:4195): (glucokinase) This gene encodes a member of the hexokinase family of proteins. Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. The use of multiple promoters and alternative splicing of this gene result in distinct protein isoforms that exhibit tissue-specific expression in the pancreas and liver. In the pancreas, this enzyme plays a role in glucose-stimulated insulin secretion, while in the liver, this enzyme is important in glucose uptake and conversion to glycogen. Mutations in this gene that alter enzyme activity have been associated with multiple types of diabetes and hyperinsulinemic hypoglycemia. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-44146445-C-T is Benign according to our data. Variant chr7-44146445-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 377918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-44146445-C-T is described in Lovd as [Likely_benign]. Variant chr7-44146445-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00309 (471/152286) while in subpopulation NFE AF= 0.00547 (372/68012). AF 95% confidence interval is 0.00501. There are 2 homozygotes in gnomad4. There are 213 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GCKNM_000162.5 linkuse as main transcriptc.1019+18G>A intron_variant ENST00000403799.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GCKENST00000403799.8 linkuse as main transcriptc.1019+18G>A intron_variant 1 NM_000162.5 P1P35557-1

Frequencies

GnomAD3 genomes
AF:
0.00310
AC:
472
AN:
152168
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000748
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00339
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00547
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.00315
AC:
752
AN:
238614
Hom.:
1
AF XY:
0.00308
AC XY:
402
AN XY:
130428
show subpopulations
Gnomad AFR exome
AF:
0.000442
Gnomad AMR exome
AF:
0.00227
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000197
Gnomad FIN exome
AF:
0.00503
Gnomad NFE exome
AF:
0.00517
Gnomad OTH exome
AF:
0.00399
GnomAD4 exome
AF:
0.00412
AC:
5966
AN:
1448140
Hom.:
19
Cov.:
33
AF XY:
0.00403
AC XY:
2909
AN XY:
720946
show subpopulations
Gnomad4 AFR exome
AF:
0.000658
Gnomad4 AMR exome
AF:
0.00255
Gnomad4 ASJ exome
AF:
0.000153
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000174
Gnomad4 FIN exome
AF:
0.00450
Gnomad4 NFE exome
AF:
0.00490
Gnomad4 OTH exome
AF:
0.00282
GnomAD4 genome
AF:
0.00309
AC:
471
AN:
152286
Hom.:
2
Cov.:
33
AF XY:
0.00286
AC XY:
213
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.000746
Gnomad4 AMR
AF:
0.00183
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00339
Gnomad4 NFE
AF:
0.00547
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00323
Hom.:
1
Bravo
AF:
0.00275

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 03, 2023Variant summary: GCK c.1019+18G>A alters a non-conserved nucleotide located at a position not widely known to affect splicing. Three computational tools predict that the variant abolishes a cryptic 5' splicing donor site but does not affect the canonical splice site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0032 in 239030 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 126-fold of the estimated maximal expected allele frequency for a pathogenic variant in GCK causing Monogenic Diabetes phenotype (2.5e-05), strongly suggesting that the variant is benign. c.1019+18G>A has been reported in the literature in individuals affected with diabetes and hyperinsulinism without evidence of cosegregation with disease (e.g. Lehto_1999, Johansen_2005, Lukasova_2008, Odem_2009, Snider_2013). These reports do not provide unequivocal conclusions about association of the variant with Monogenic Diabetes. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 10447526, 14517946, 15928245, 18271687, 19515026, 23275527). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 06, 2020The c.1016+18G>A variant in GCK classified as benign because it has been identified in 0.5% (660/125912) of European chromosomes, including 2 homozygote occurences, by gnomAD (http://gnomad.broadinstitute.org). In additon, it is not located within the splice consensus sequence and computational splice prediction tools predict disruption of a cryptic splice at this position without effect on the canonical splice. It has been reported in ClinVar (Variation ID: 377918). ACMG/AMP Criteria applied: BS1, BP4, BP7. -
Likely benign, criteria provided, single submitterclinical testingGeneDxJan 07, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2022GCK: BP4 -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 31, 2017- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 15, 2024- -
Type 2 diabetes mellitus;C0342277:Maturity-onset diabetes of the young type 2;C1865290:Hyperinsulinism due to glucokinase deficiency;C5393570:Permanent neonatal diabetes mellitus 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 12, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
Cadd
Benign
5.1
Dann
Benign
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150914617; hg19: chr7-44186044; API